Get the Stockscreener App
3.12
0.32%
-0.010
Vivos Therapeutics Inc stock is traded at $3.12, with a volume of 359.29K.
It is down -0.32% in the last 24 hours and down -18.11% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$3.13
Open:
$3.1
24h Volume:
359.29K
Relative Volume:
1.18
Market Cap:
$23.41M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.5493
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
-2.19%
1M Performance:
-18.11%
6M Performance:
+36.24%
1Y Performance:
+35.06%
1-Day Range:
$3.07
$3.22
1-Week Range:
$3.06
$3.42
52-Week Range:
$1.98
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
3.12 | 23.49M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Is Vivos Therapeutics Inc. stock dividend yield sustainableQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
How supply chain issues affect Vivos Therapeutics Inc. stockJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Price momentum metrics for Vivos Therapeutics Inc. explainedProduct Launch & Low Risk Investment Opportunities - newser.com
How to integrate Vivos Therapeutics Inc. into portfolio analysis toolsMarket Activity Report & Free Daily Entry Point Trade Alerts - newser.com
Predicting Vivos Therapeutics Inc. trend using moving averages2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Vivos Therapeutics Inc. stock chart pattern explainedJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Has Vivos Therapeutics Inc. found a price floorEntry Point & Expert Curated Trade Setup Alerts - newser.com
Historical volatility pattern of Vivos Therapeutics Inc. visualizedBuy Signal & Reliable Price Breakout Signals - newser.com
How moving averages guide Vivos Therapeutics Inc. tradingEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders - MSN
Is Vivos Therapeutics Inc. forming a reversal pattern2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com
Vivos Therapeutics (NASDAQ:VVOS) Shares Down 1% – Time to Sell? - Defense World
What drives Vivos Therapeutics Inc stock priceGap Fill Strategies & Low Entry Investment Plans - earlytimes.in
Vivos Therapeutics Reports Clinical Data Showing Significant Improvement in ADHD and OSA Symptoms in Children Using FDA-Cleared DNA Appliance - Quiver Quantitative
58% Drop in ADHD Symptoms: Vivos' FDA-Cleared Sleep Device Shows Breakthrough in Children's Treatment - Stock Titan
What analysts say about Vivos Therapeutics Inc stockTrendline Breakouts & High Yield Investment Tips - earlytimes.in
Vivos Therapeutics Inc Stock Analysis and ForecastMarket Insider Reports & Affordable Capital Growth - earlytimes.in
The Future of Sleep Apnea Treatment: Vivos’ Oral Appliance Technology Offers an Alternative to CPAP - MarketScale
Will Vivos Therapeutics Inc. rebound enough to break even2025 EndofYear Setup & Safe Capital Investment Plans - newser.com
Using economic indicators to assess Vivos Therapeutics Inc. potentialRate Hike & Safe Swing Trade Setups - newser.com
Comparing Vivos Therapeutics Inc. in custom built stock radarsMarket Movement Recap & Community Supported Trade Ideas - newser.com
Market Catalysts: What are Vivos Therapeutics Incs earnings expectationsEarnings Risk Report & Consistent Income Trade Ideas - خودرو بانک
Quarterly Recap: Is Vivos Therapeutics Inc. part of any ETFIndex Update & Risk Controlled Swing Alerts - khodrobank.com
Growth Value: What’s the outlook for NNBR’s sectorJuly 2025 EndofMonth & Momentum Based Trading Ideas - khodrobank.com
Gains Report: What is the dividend yield of Vivos Therapeutics IncStop Loss & Low Risk Growth Stock Ideas - خودرو بانک
Analysis Recap: Is Vivos Therapeutics Inc showing insider buyingJuly 2025 Volume & Technical Pattern Based Signals - خودرو بانک
Published on: 2025-09-19 19:22:53 - newser.com
Momentum Shift: Does Cheer Holding Inc stock reflect fundamentalsM&A Rumor & Long-Term Safe Investment Plans - خودرو بانک
What recovery options are there for Vivos Therapeutics Inc.2025 Market Sentiment & Daily Market Momentum Tracking - newser.com
Vivos’ DNA appliance shows promise for children with sleep apnea - Investing.com India
How high can Vivos Therapeutics Inc. stock goJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
What does recent volatility data suggest for Vivos Therapeutics Inc.Quarterly Market Summary & Reliable Price Action Trade Plans - newser.com
Order flow analysis tools used on Vivos Therapeutics Inc.2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Vivos’ DNA appliance shows promise for children with sleep apnea By Investing.com - Investing.com South Africa
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):